ĀÜĄņĀŅĀ×

Dr. Grossman has over 25 years of extensive experience leading successful global clinical organizations and currently serves as SVP, Oncology Clinical Research at Gilead Sciences. Previously, Dr. Grossman served as Chief Medical Officer (CMO) of Arcus Biosciences and CMO of Bellicum Pharmaceuticals, responsible for its clinical development, regulatory affairs, clinical operations, and medical affairs organizations. Dr. Grossman was the Global Group Medical Director for Cancer Immunotherapy at Genentech, and prior to Genentech, held leadership roles in oncology and immunology at AbbVie, Biothera, Baxter Healthcare, and Merck & Co.

Prior to joining the industry, Dr. Grossman held various positions with the Childrenā€™s Hospital of Wisconsin/Medical College of Wisconsin where he was Founder and Medical Director of the Clinical Immunodiagnostic and Research Laboratory, Professor for Microbiology and Genetics, and Director of the Hematology/Oncology/Bone Marrow Transplant Division for the Immunodeficiency Transplant Program.

Dr. Grossman holds a BA in Biology and Chemistry from University of St. Thomas, St. Paul, Minnesota (Magna Cum Laude) and MD and PhD (Immunology) degrees from Washington University School of Medicineā€™s Medical Scientist Training Program. He completed his medical training in the Division of Pediatric Biology/Medicine at the Washington University School of Medicine.